Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:18224418rdf:typepubmed:Citationlld:pubmed
pubmed-article:18224418lifeskim:mentionsumls-concept:C0023467lld:lifeskim
pubmed-article:18224418lifeskim:mentionsumls-concept:C0205419lld:lifeskim
pubmed-article:18224418lifeskim:mentionsumls-concept:C1515794lld:lifeskim
pubmed-article:18224418lifeskim:mentionsumls-concept:C1533148lld:lifeskim
pubmed-article:18224418lifeskim:mentionsumls-concept:C0679622lld:lifeskim
pubmed-article:18224418lifeskim:mentionsumls-concept:C0205314lld:lifeskim
pubmed-article:18224418pubmed:issue1lld:pubmed
pubmed-article:18224418pubmed:dateCreated2008-1-28lld:pubmed
pubmed-article:18224418pubmed:abstractTextWe encountered a case of acute myeloblastic leukemia (AML), with extramedullary leukemia (EML) and a masked type of the variant translocation t(8;21)(q22;q22). Morphologically, the AML M2 subtype according to the French-American-British (FAB) classification was present. Phenotypically, leukemic cells were negative for CD19 and positive for CD56. Clinically, the case showed chemo-refractoriness and a poor outcome. The initial karyotypic interpretation was t(8;9)(q22;q34) on G-banding. Multiplex-fluorescence in situ hybridization (multiplex-FISH) analysis revealed a three-way translocation involving chromosomes 8, 9, and 21, and identified a masked type of variant t(8;21)q22;q22) translocation. The karyotype was finally determined as 45,X,-Y,der(8)t(8;21)(q22;q22), der(9)(8;9)(q22;q34), and der(21)t(9;21)(q34;q22). Results of FISH using the AML1/ETO probe and detection of the AML1/ETO fusion transcripts by reverse transcriptase-polymerase chain reaction (RT-PCR) support the karyotype as well as the sequence of the PCR product. Additionally, C-KIT mutation was detected.lld:pubmed
pubmed-article:18224418pubmed:languageenglld:pubmed
pubmed-article:18224418pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18224418pubmed:citationSubsetIMlld:pubmed
pubmed-article:18224418pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18224418pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18224418pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18224418pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18224418pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18224418pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18224418pubmed:statusMEDLINElld:pubmed
pubmed-article:18224418pubmed:monthJanlld:pubmed
pubmed-article:18224418pubmed:issn0925-5710lld:pubmed
pubmed-article:18224418pubmed:authorpubmed-author:MiuraIkuoIlld:pubmed
pubmed-article:18224418pubmed:authorpubmed-author:NishiiKazuhir...lld:pubmed
pubmed-article:18224418pubmed:authorpubmed-author:NakaoMakotoMlld:pubmed
pubmed-article:18224418pubmed:authorpubmed-author:YamamoriShunj...lld:pubmed
pubmed-article:18224418pubmed:authorpubmed-author:MitaniHidetsu...lld:pubmed
pubmed-article:18224418pubmed:authorpubmed-author:MurataTetsuya...lld:pubmed
pubmed-article:18224418pubmed:authorpubmed-author:KawakamiKeiki...lld:pubmed
pubmed-article:18224418pubmed:authorpubmed-author:WatanabeYasuy...lld:pubmed
pubmed-article:18224418pubmed:authorpubmed-author:MonmaFumihiko...lld:pubmed
pubmed-article:18224418pubmed:authorpubmed-author:HosokaiNoboru...lld:pubmed
pubmed-article:18224418pubmed:authorpubmed-author:RyuuHyouHlld:pubmed
pubmed-article:18224418pubmed:issnTypePrintlld:pubmed
pubmed-article:18224418pubmed:volume87lld:pubmed
pubmed-article:18224418pubmed:ownerNLMlld:pubmed
pubmed-article:18224418pubmed:authorsCompleteYlld:pubmed
pubmed-article:18224418pubmed:pagination78-82lld:pubmed
pubmed-article:18224418pubmed:meshHeadingpubmed-meshheading:18224418...lld:pubmed
pubmed-article:18224418pubmed:meshHeadingpubmed-meshheading:18224418...lld:pubmed
pubmed-article:18224418pubmed:meshHeadingpubmed-meshheading:18224418...lld:pubmed
pubmed-article:18224418pubmed:meshHeadingpubmed-meshheading:18224418...lld:pubmed
pubmed-article:18224418pubmed:meshHeadingpubmed-meshheading:18224418...lld:pubmed
pubmed-article:18224418pubmed:meshHeadingpubmed-meshheading:18224418...lld:pubmed
pubmed-article:18224418pubmed:meshHeadingpubmed-meshheading:18224418...lld:pubmed
pubmed-article:18224418pubmed:meshHeadingpubmed-meshheading:18224418...lld:pubmed
pubmed-article:18224418pubmed:meshHeadingpubmed-meshheading:18224418...lld:pubmed
pubmed-article:18224418pubmed:meshHeadingpubmed-meshheading:18224418...lld:pubmed
pubmed-article:18224418pubmed:meshHeadingpubmed-meshheading:18224418...lld:pubmed
pubmed-article:18224418pubmed:meshHeadingpubmed-meshheading:18224418...lld:pubmed
pubmed-article:18224418pubmed:year2008lld:pubmed
pubmed-article:18224418pubmed:articleTitleA case of acute myeloblastic leukemia with a novel variant of t(8;21)(q22;q22).lld:pubmed
pubmed-article:18224418pubmed:affiliationDivision of Hematology and Oncology, Suzuka General Hospital, Suzuka, Mie, Japan. Kawakei@cocoa.ocn.ne.jplld:pubmed
pubmed-article:18224418pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:18224418pubmed:publicationTypeCase Reportslld:pubmed